Allergy Desensitization Therapy: The Full Multi-Year Program
Allergy desensitization therapy is subcutaneous immunotherapy (SCIT) framed as a multi-year treatment program — not a single intervention. The arc: IgE-confirmed sensitization → extract prescription → 24-28 weekly build-up visits → 3-5 years of maintenance every 2-4 weeks → disease-modifying remission persisting years after stopping (Durham 1999 NEJM). Real-world completion: 43.9% of initiators reach maintenance (Tkacz 2021).
6 peer-reviewed sources
Allergy desensitization therapy is a 3-to-5-year SCIT program: build-up phase of 24-28 weekly injections, then maintenance every 2-4 weeks, totaling 60-80+ clinic visits — not a one-time or short-course treatment.
The essentials
Allergy desensitization therapy is subcutaneous immunotherapy (SCIT) understood as a treatment program rather than a single procedure. The 'therapy' suffix carries genuine weight: this is a multi-year course with a defined arc that the patient, the allergist, and often the insurer all need to understand before starting.
The therapy arc as defined in the AAAAI/ACAAI/JCAAI Practice Parameter Third Update (Cox L, Nelson H, Lockey R et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1-S55, DOI 10.1016/j.jaci.2010.09.034) involves five stages:
1. IgE-confirmed sensitization. Only patients with a positive skin prick test (wheal ≥3 mm above negative control) or specific IgE blood test (≥0.35 kUA/L) with symptomatic correlation are candidates for desensitization therapy per Cox 2011.
2. Extract prescription. The allergist prescribes a custom-compounded allergen extract vial targeting confirmed sensitizations — single-allergen or multi-allergen per Cox 2011 Summary Statement 72. Vials are prepared from FDA-licensed extracts from manufacturers including Stallergenes Greer and ALK-Abelló.
3. Build-up phase. Conventional: 1-2 injections per week for 3-6 months (~24-28 visits) to maintenance. Cluster alternative: 2-4 injections per visit at 30-minute intervals, reaching maintenance in 4-8 weeks (Tabar AI et al., J Allergy Clin Immunol 2005;116:109-118). Rush: 1-3 days of intensive injections (Bernstein DI et al., J Allergy Clin Immunol 2008;122(2)). A mandatory 30-minute observation follows each injection regardless of schedule.
4. Maintenance phase. Every 2-4 weeks for 3-5 years. The 30-minute observation applies at each maintenance visit.
5. End-of-treatment reassessment. At 3-5 years, the allergist and patient assess whether to continue or discontinue. Durability evidence: Durham SR et al. (N Engl J Med 1999;341:468-475) demonstrated remission persisting years after a 3-4 year grass-pollen course ended.
Curex's at-home IgE blood test with allergist review confirms which allergens to target before committing to a multi-year desensitization therapy — so the prescription matches the patient's actual sensitization profile.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The allergy desensitization therapy timeline is the program arc that distinguishes it from a single treatment or a short course.
Conventional build-up: 24-28 weekly injection visits escalating from 0.05 mL to 0.5 mL of maintenance concentrate. Cluster (Tabar 2005 JACI): maintenance in 4-8 weeks at higher per-injection systemic-reaction risk. Rush (Bernstein 2008 JACI): 1-3 days, pre-medication required; systemic-reaction risk up to approximately 36% historically. 30-minute observation mandatory after every injection.
Maintenance injections continue every 2-4 weeks. By year three, most patients are coming in once a month for a 5-minute injection plus 30-minute observation. Gaps of 3-4+ months require restarting from an earlier dilution. Disease benefits accumulate throughout maintenance and peak at 1-2 years of maintenance.
Durham SR et al. (N Engl J Med 1999;341:468-475): sustained remission after a 3-4 year grass-pollen SCIT course. Jacobsen L et al. (Allergy 2007, PAT 10-year follow-up): children completing SCIT showed OR 4.6 (95% CI 1.5-13.7) for asthma prevention. The therapy is the arc — not the individual appointment.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
How long is allergy desensitization therapy?
Allergy desensitization therapy (SCIT) lasts 3-5 years total. Build-up phase: approximately 24-28 weekly visits over 3-6 months (conventional); 4-8 weeks with cluster protocols (Tabar AI et al., JACI 2005;116:109-118). Maintenance phase: every 2-4 weeks for 3-5 years. Total: approximately 60-80+ injection visits. After completing the course, disease-modifying remission persists for an average of 3-12 years without further treatment per Durham SR et al. (N Engl J Med 1999;341:468-475). This is the 'therapy arc' — not a single treatment or a short course.
What does allergy desensitization therapy involve week by week?
During build-up, each weekly visit involves: pre-injection screening for contraindications (asthma status, fever, new medications), vial verification, subcutaneous injection of escalating allergen volume (0.05 mL start, 0.5 mL maintenance target), mandatory 30-minute at-home observation, and local-reaction measurement. During maintenance, visits are every 2-4 weeks using the maintenance-concentrate dose. The protocol is identical at every visit — it is the consistency of the allergen exposure that produces the immunological reprogramming. Patients can expect the injection itself to take 30 seconds and the visit to last approximately 35-40 minutes including observation.
Does allergy desensitization therapy work for everyone?
Allergy desensitization therapy works for the majority of patients who complete the full course. Cochrane meta-analysis (Calderón MA et al., 2007, 51 RCTs / 2,871 patients) found a symptom SMD of -0.73 and a medication SMD of -0.57. However, response rates vary by allergen — strongest evidence for grass pollen, ragweed, cat dander, house dust mite, and Hymenoptera venom; weaker for dog dander and some molds. Non-responders after 1 year of therapy may warrant reassessment of their sensitization profile or treatment compliance. Real-world completion rate is 43.9% (Tkacz 2021), so benefit is most reliably achieved by patients who commit to the full therapy arc.
What are the side effects of allergy desensitization therapy?
Local reactions at the injection site occur in approximately 16.3% of injections — redness, swelling, and itching are expected immune activation. Large local reactions (swelling over 25 mm) occur in approximately 0.4% of injections. Systemic reactions occur in approximately 0.1% of injection visits and include hives, sneezing, or mild wheezing beginning outside the injection site (WAO grade 1-2). Anaphylaxis is very rare — one confirmed fatality per 23.3 million US injection visits (Epstein 2014). If you experience throat tightness, difficulty breathing, generalized hives, or lightheadedness after an injection, call 911 immediately and use an epinephrine auto-injector if available.
How much does allergy desensitization therapy cost?
Cost depends on insurance coverage, practice setting, and treatment duration. CMS billing codes per Article A57472: CPT 95115 (single injection), CPT 95117 (two or more injections per visit), CPT 95165 (vial preparation per dose). Most commercial insurance covers allergy desensitization therapy under major medical. Hospital outpatient (HOPD) billing can add substantial facility fees — one documented case showed $24,400 annual HOPD billing versus $1,711 at a standalone allergist office for the same therapy (WPSU, Geisinger 2026). For detailed cost and insurance information, see the dedicated cost and insurance pages.
Can allergy desensitization therapy be done with drops instead of shots?
Yes — sublingual immunotherapy (SLIT) drops deliver the same dose-escalation desensitization principle as SCIT, using the same allergen-specific tolerance mechanism (Treg induction, IgG4 blocking antibodies) but administered under the tongue rather than by injection. SLIT drops require the same 3-5 year course duration. They can be taken at home after a medically supervised introduction, eliminating the weekly clinic visit and 30-minute observation requirement of SCIT. SLIT drops have zero confirmed fatalities worldwide. The trade-off: FDA-approved SLIT tablets are limited to single allergens (Grastek for grass, Ragwitek for ragweed, Odactra for dust mite); compounded SLIT drops can include multiple allergens but are off-label.
Related Articles
Cat Allergy Shot for Humans | Curex SCIT Guide
This page covers cat allergy shots FOR HUMANS — SCIT with FDA-standardized Fel d 1 extract (10,000 BAU/mL). Not Cytopoint. Not Apoquel. ~72% symptom reduction in RCTs.
Read moreAllergy Desensitization Shots Guide | Curex
Allergy desensitization shots are the 20th-century term for SCIT. Cochrane 2007 (51 RCTs) found symptom SMD -0.73. Learn the current terminology and evidence.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreAllergy Injection Site: Anatomy & Technique | Curex
SCIT injections go subcutaneously into the posterolateral upper outer arm, alternating arms each visit. 26-27G needle. Not intramuscular. Not intradermal.
Read moreAllergy Treatment Shots: SCIT Evidence Guide | Curex
Allergy treatment shots (SCIT): ~39 Year-1 visits per Cox 2011. Cochrane SMD -0.73. Durham 1999: 3-yr course, 4-yr remission. Who qualifies inside.
Read moreAllergy Shot For Humans: SCIT & SLIT Guide
Yes, there is an allergy shot for humans — subcutaneous immunotherapy (SCIT). Cochrane SMD −0.73, 3–5 yr course, at home via Curex $129/mo. Not Cytopoint.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.